Potential conflict of interest: Nothing to report.
Article first published online: 24 JUN 2011
Copyright © 2011 American Association for the Study of Liver Diseases
Volume 54, Issue 1, pages 367–368, July 2011
How to Cite
Horiguchi, N. and Gao, B. (2011), Reply:. Hepatology, 54: 367–368. doi: 10.1002/hep.24383
- Issue published online: 24 JUN 2011
- Article first published online: 24 JUN 2011
- Accepted manuscript online: 21 APR 2011 01:16PM EST
- Manuscript Accepted: 8 APR 2011
- Manuscript Received: 7 APR 2011
We highly appreciate the comments by Weng and colleagues. Our laboratory has been focusing on the role of inflammation in liver injury, fibrosis, and regeneration by using a model of myeloid cell–specific signal transducer and activator of transcription 3 (STAT3) knockout (STAT3mye−/−) mice. As it was previously reported, STAT3mye−/− mice are highly susceptible to endotoxin shock with increased production of inflammatory cytokines.1 We demonstrated that STAT3mye−/− mice were resistant to liver damage after carbon tetrachloride (CCl4) injection,2 but more susceptible to concanavalin A–induced and ethanol-induced liver damage, accompanied by more inflammatory cells in the liver.3, 4 We believe, as Weng and colleagues summarized, the balance between pro- and anti-inflammatory cytokines determines the fate of hepatocyte survival or death. These results suggest that the etiology of liver injury determines whether inflammatory cells contribute to attenuating or worsening liver damage.
Weng et al. also raised an important point regarding the effect of inflammation on liver fibrogenesis. Although we have not examined CCl4-induced chronic liver injury and fibrosis in STAT3mye−/− mice, the effects of inflammation on fibrogenesis in these mice may be complex. Inflammation not only contributes to fibrogenesis, but also plays an important role in the resolution of liver fibrosis.5 In our study, STAT3mye−/− mice had high levels of liver inflammation associated with higher levels of tumor necrosis factor-α, interleukin-1 (IL-1), and IL-6, which are known to promote liver fibrosis, but also higher levels of IL-10 and interferon-γ, which are known to inhibit liver fibrosis. The balance between these pro- and antifibrogenic cytokines will likely play an important role in determining the progression of liver fibrogenesis in STAT3mye−/− mice after chronic CCl4 treatment.
- 1Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999; 10: 39-49., , , , , , et al.
- 2Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell-specific signal transducer and activator of transcription 3 gene knockout mice. HEPATOLOGY 2010; 51: 1724-1734., , , , , , et al.
- 3Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production. Gastroenterology 2009; 137: 2125-2135., , , , , , et al.
- 4Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury. Gastroenterology 2008; 134: 1148-1158., , , , , , et al.
- 5Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005; 115: 56-65., , , , , , et al.
Norio Horiguchi M.D. , Ph.D.* , Bin Gao M.D., Ph.D., * Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Gunma, Japan.